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 What does Diabetes have to do with  
Cognition and Swallowing? 
 
Marnie Kershner and Paula Leslie 
 
Abstract  
Speech-language pathologists working with adults in medical settings are likely to encounter patients with a diagnosis of diabetes 
mellitus on a regular basis (NCD Risk Factor Collaboration, 2016). The current literature supports an association between diabetes 
and mild cognitive impairment (Moreira, Soldera, Cury, Meireles, & Kupfer, 2015; Vincent & Hall, 2015). Mild impairments in 
executive functioning are of particular relevance in this population. Even within the range of normal cognitive abilities, reduced 
executive functioning can negatively impact patients’ self-management of their diabetes (and potentially adherence to therapy 
programs and strategies) and therefore their overall health. Mild cognitive deficits in this population are therefore clinically relevant 
and may warrant intervention (Vincent & Hall, 2015). Diabetic complications may also impact digestion, indirectly impacting 
patients’ intake and tolerance of food and drink (Borgnakke, Anderson, Shannon, & Jivanescu, 2015; Gatopoulou, Papanas, & 
Maltezos, 2012; Hüppe et al., 1992; Sandberg, Sundberg, Fjellstrom, & Wikblad, 2000).   
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Learning Objectives  
1) Describe common complications of diabetes. 
2) Describe cognitive impairments associated with 
diabetes. 





Diabetes is a chronic, progressive disease with the 
potential to lead to significant disability. Diabetes 
impacts endocrine and vascular function. Type I 
diabetes is typically diagnosed in childhood or early 
adulthood where the body does not make its own 
insulin and people need to take insulin daily. Type II is 
typically diagnosed in adulthood (Unger, 2013). Type II 
is more common than type I accounting for 90-95% of 
all diabetes cases in the US (Ghosh & Collier, 2012; 
National Institute of Diabetes and Digestive and Kidney 
Diseases [NIDDK], 2016). According to a 2017 report 
from the Centers for Disease Control and Prevention, 
approximately 30.3 million people in the US had 
diabetes equivalent to the populations of New York and 
Michigan states combined (CDC, 2017).
In type II diabetes the body destroys insulin-producing 
beta cells of the pancreas (necessary for blood sugar 
regulation) and develops insulin resistance.  
 
Macrovasculature (large blood vessels) and 
microvasculature (small blood vessels) can be damaged 
in diabetes. Common microvascular complications 
include retinopathy, nephropathy and neuropathy. 
These are vascular-based disorders of the eyes, kidneys 
and nerves respectively (Ghosh & Collier, 2012). Distal 
structures such as the hands and feet are typically 
affected first because they are especially rich in 
microvasculature. The microvasculature of the digestive 
tract and brain are also susceptible. The blood supply to 
nerves may be progressively destroyed (i.e., 
neuropathy) in diabetes resulting in the progressive 
reduction of viable nerves (Moreira, Soldera, Cury, 
Meireles & Kupfer, 2015) as nerves require adequate 
blood supply to function and survive.  Risk factors for 
diabetic neuropathy include obesity, hypertension, 
tobacco use, a family history of diabetic neuropathy and 
advancing age (Unger, 2013).  
 
So how do patients with diabetes fit into the speech-
language pathology scope of practice? The American 
Speech-Language Hearing Association (ASHA) supports 
and encourages speech-language pathologists (SLPs) to 
contribute to the interdisciplinary care of patients with 
cognitive, communication and/or swallowing 
impairments secondary to neurological disease resulting 
in functional deficits (ASHA, 2016). Patients with 
diabetes may fit into this category with complications 
such as neuropathic impairments of cognition and/or 
swallow function. Understanding how diabetes 
complications can contribute to impairments within the 
SLPs’ scope of practice is necessary to providing 
individualized, evidence-based care. The SLP’s role may 
include screening, assessment, treatment, patient 
advocacy, education, counseling and/or referring to 
other professionals.   
 
Diabetic Complications: Cognition  
Type II diabetes has been found to be associated with 
reduced performance on executive functioning tasks in 
adults. In a 2015 meta-analysis, adults with type II 
diabetes showed reduced performance across executive 
functioning tasks when compared to healthy controls 
(verbal fluency, mental flexibility, inhibition and 
attention) (Vincent & Hall, 2015). The effect sizes across 
executive function domains were small, but consistent 
and these findings are clinically relevant. Impaired 
executive functioning, even within the normal range “… 
has been linked to worse adherence to medical 
treatment, physical activity non-adherence, and worse 
dietary control, all of which are important to adequate 
[type II diabetes] management” (Vincent & Hall, 2015, 
p.639).  
 
Studies of animal models with microvascular disease 
due to diabetes have found functional and structural 
changes in the brains of these animals. These changes 
caused impaired cerebral perfusion (blood flow) and 
impaired neural recovery after insult (e.g., following a 
cerebrovascular accident or traumatic brain injury) 
(De Silva & Faraci, 2016). These findings help us 
hypothesize what the underlying mechanisms of 
cognitive-communication impairment may be in 
humans with diseases impacting the microvasculature. 
At present, the clinical literature on this topic in human 
subjects is limited and inconclusive (Moreira et al., 
2015). 
 
SLPs working with adults in healthcare settings are 
aware that medical diagnoses rarely present in 
isolation, particularly for older adults (≥65 years). 
Approximately 60% of older adults with diabetes have 
at least one additional chronic medical condition; up to 
40% have ≥4 chronic medical conditions (Huang, 2016). 
Older adults may have multiple chronic medical 
conditions that carry risk for cognitive impairment. As 
an example: older hospitalized adults with heart failure 
scored poorer on the Mini Mental State Exam when 
compared to healthy controls and those who also had 
diabetes scored even lower (Basile et al., 2013).  
 
Diabetic Complications: The Digestive Tract  
Safe and comfortable tolerance of an oral diet requires 
more than the safe passage of food and drink through 
the upper esophageal sphincter. The entire digestive 
tract plays a role. Diabetes can have harmful effects 
throughout the digestive tract. Starting in the mouth, 
diabetes is associated with a higher risk for poor oral 
health – and consequently – poor oral hygiene 
(Borgnakke, Anderson, Shannon, & Jivanescu, 2015; 
Sandberg, Sundberg, Fjellstron & Wikblad, 2000). Poor 
oral hygiene, in the setting of aspiration or oral 
secretions, is an established risk factor for developing 
pneumonia (Yoneyama et al., 2002). In an exploratory 
case-control study the prevalence of xerostomia (i.e., 
dry mouth), advanced periodontitis, oral mucosa 
abnormalities, plaque and bleeding gums were 
significantly greater in adults with type II diabetes when 
compared to healthy controls (Sandberg et al., 2000).  
 
Autonomic neuropathy (primarily affecting nerves that 
regulate internal organs) related to diabetes can result 
in additional dysfunction further down the digestive 
tract (Gatopoulou, Papnas & Maltezos, 2012; Hüppe et 
al., 1992). These impairments include esophageal 
dysmotility, gastroesophageal reflux disease (GERD), 
gastroparesis (impaired emptying of the stomach), 
constipation, diarrhea and fecal incontinence. These 
impairments in digestion are essential for the SLP to be 
aware of because they impact patients’ tolerance of 
oral diets, and may increase risk for aspiration of gastric 
contents (as may be the case for a patient with 




With advanced age and multiple chronic medical 
conditions (a common combination in older adults with 
diabetes) comes a greater risk of polypharmacy. 
Polypharmacy may be defined as “…the use of more 
medications than are medically necessary”  (Maher, 
Hanlon & Hajjar, 2014, p. 1). Others define 
polypharmacy as the use of multiple medications at one 
time, with various cut-offs for the number of 
medications. Medication side effects can trigger a 
prescription cascade; drugs can start to be added to a 
patient’s list to manage symptoms that are actually side 
effects of other medications (Wise, 2013). Adverse 
medication interactions and medication side effects can 
cause or contribute to deficits in cognition and swallow 
function (Gallagher & Naidoo, 2009; Maher et al., 2014). 
Dysphagia may be induced by medications, or indirectly 
impacted by medications (e.g., reduced nutritional 
status, dehydration, dry mouth, impaired taste, reduced 
oral hygiene/health) (Gallagher & Naidoo, 2009). When 
in doubt, it is appropriate for the SLP to suggest that the 
medical team consider a medication review with the 
aim to reduce the overall burden on the patient.  
 
Recommendations for Management - SLP Role 
Diabetes is associated with mild cognitive impairments 
(Moreira et al., 2015; Vincent & Hall, 2015). Mild 
impairments in executive functioning, even within the 
range of normal, are clinically relevant and may warrant 
intervention (Vincent & Hall, 2015). Careful screening 
and higher-level assessment should be considered to 
identify subtle impairments in patients with diabetes. 
 
Cognitive treatment should focus on functional 
compensatory strategies, taught in the context of daily 
tasks relevant to patients’ specific needs (Moro et al., 
2015). For patients with diabetes, tasks may relate to 
increasing independence in disease management (e.g., 
monitoring blood sugar, managing medications). 
Significant others and/or caregivers should be included 
in treatment when possible to support generalization 
(Moro et al., 2015). Referrals to dentistry and 
gastroenterology are encouraged given the established 
associations between diabetes (± diabetic neuropathy) 
and poor oral health (Borgnakke et al., 2015; Sandberg 
et al., 2000), and between diabetic neuropathy and a 
variety of gastrointestinal (GI) complications 
(Gatopoulou et al., 2012; Hüppe et al., 1992). 
 
Practicalities of Management. The SLPs role in 
addressing cognition in patients with diabetes may 
include advocacy, screening, assessment, treatment, 
counseling, education and/or onward referrals.  
• Executive functioning impairments are of 
particular concern in this population, and 
especially for individuals who do not have daily 
assistance with diabetes management. When in 
doubt, screen.  
• Treatment should be functional and related to 
the patient’s specific day-to-day needs.  
• Significant others and/or caregivers should be 
involved when possible to support carryover.  
• The Mild Cognitive Impairment Questionnaire 
(Dean, Jenkinson, Wilcock, & Walker, 2014) 
evaluates emotional and practical quality of life 
concerns in adults with mild cognitive 
impairment and may be a helpful tool to 
consider for patients in this population.  
 
Interdisciplinary Considerations.  When responding to 
swallow consults for patients with diabetes (especially 
for consults related to “poor PO intake”) the SLP should 
remember that the oropharynx does not exist in 
isolation. While periodontitis and gastroparesis are 
outside of the SLP scope – making appropriate referrals 
is within the SLP scope. 
• Such referrals may be made to:  
o Dentistry 
o Gastroenterology  
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